Page last updated: 2024-08-23

pirfenidone and Primary Graft Dysfunction

pirfenidone has been researched along with Primary Graft Dysfunction in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dupont, LJ; Gheysens, O; Godinas, L; Goffin, KE; Heigl, T; McDonough, JE; Neyrinck, AP; Sacreas, A; Schaevers, V; Van Herck, A; Van Raemdonck, DE; Vanaudenaerde, BM; Verbeken, EK; Verleden, GM; Verleden, SE; Vos, R; Wuyts, WA; Yserbyt, J	1
Behr, J; Ceelen, F; Crispin, A; Kneidinger, N; Leuschner, G; Meiser, B; Michel, S; Milger, K; Munker, D; Neurohr, C; Schmitzer, M; Schneider, C; Sisic, A; Veit, T; Weig, T	1

Other Studies

2 other study(ies) available for pirfenidone and Primary Graft Dysfunction

Article	Year
Pirfenidone in restrictive allograft syndrome after lung transplantation: A case series. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2018, Volume: 18, Issue:12 Topics: Allografts; Anti-Inflammatory Agents, Non-Steroidal; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Lung Diseases; Lung Transplantation; Male; Middle Aged; Postoperative Complications; Primary Graft Dysfunction; Prognosis; Pulmonary Fibrosis; Pyridones; Retrospective Studies; Risk Factors; Syndrome	2018
Pirfenidone exerts beneficial effects in patients with IPF undergoing single lung transplantation. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2019, Volume: 19, Issue:8 Topics: Anti-Inflammatory Agents, Non-Steroidal; Combined Modality Therapy; Female; Follow-Up Studies; Germany; Graft Rejection; Graft Survival; Humans; Idiopathic Pulmonary Fibrosis; Incidence; Lung Transplantation; Male; Middle Aged; Primary Graft Dysfunction; Pyridones; Retrospective Studies; Treatment Outcome	2019

Article

Year

Pirfenidone in restrictive allograft syndrome after lung transplantation: A case series.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2018, Volume: 18, Issue:12

Topics: Allografts; Anti-Inflammatory Agents, Non-Steroidal; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Lung Diseases; Lung Transplantation; Male; Middle Aged; Postoperative Complications; Primary Graft Dysfunction; Prognosis; Pulmonary Fibrosis; Pyridones; Retrospective Studies; Risk Factors; Syndrome

2018

Pirfenidone exerts beneficial effects in patients with IPF undergoing single lung transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2019, Volume: 19, Issue:8

Topics: Anti-Inflammatory Agents, Non-Steroidal; Combined Modality Therapy; Female; Follow-Up Studies; Germany; Graft Rejection; Graft Survival; Humans; Idiopathic Pulmonary Fibrosis; Incidence; Lung Transplantation; Male; Middle Aged; Primary Graft Dysfunction; Pyridones; Retrospective Studies; Treatment Outcome

2019